|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00633555 |
|
Date of registration:
|
04/03/2008 |
|
Primary sponsor: |
|
|
Public title:
|
A Comparison of the Microdose Leuprolide Protocol vs. Luteal Phase Ganirelix Protocol in Women Who Are or Who Are Predicted to be Low Responders
LR |
|
Scientific title:
|
A Randomized Controlled Trial of Microdose Leuprolide Protocol vs. Luteal Phase Ganirelix Protocol in Predicted Low Responders |
|
Date of first enrolment:
|
July 2006 |
|
Target sample size:
|
54 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00633555 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case Control, Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
John Nulsen, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
The Center for Advanced Reproductive Services, P.C. |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Women ages 21-44 undergoing IVF for infertility
- Prior IVF cycle with poor response (=4 follicles on ultrasound,= 4 oocytes retrieved,
peak estradiol <1000 pg/mL, prior IVF cycle cancelled for poor response)
OR
- Predicted poor response (age >40, basal FSH =10 mIU/mL, prior poor response to
gonadotropin (peak estradiol <500 pg/mL))
Exclusion Criteria:
- Medical contraindications for oral contraceptive pills, injectable gonadotropin
medications, estradiol, or progesterone in oil use.
- Medical contraindications to pregnancy
- Prior IVF cycle with Microdose Protocol or Luteal Phase Ganirelix Protocol
Age minimum:
21 Years
Age maximum:
44 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Infertility
|
|
Primary Outcome(s)
|
|
Implantation rate
[Time Frame: 4-6 weeks]
|
|
Secondary Outcome(s)
|
|
Number of oocytes retrieved
[Time Frame: 4-6 weeks]
|
|
Secondary ID(s)
|
|
06-198-2
|
|
CARS-06-198
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|